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The antimicrobial activity of dry methanol and ethyl acetate extracts for the leaves, bark of the stem, 
peel of the root, flower, fruit and seed of Caesalpinia pyramidalis Tull. (catingueira) was performed 
against seventeen isolates of Staphylococcus aureus MRSA multiresistant strains, which included two 
isolates of S. aureus MSSA and two ATCC strains. The antimicrobial activity was tested by the agar 
diffusion method and the Minimum Inhibitory Concentration (MIC) was determined. The dry methanol 
extract of the root showed good antimicrobial activity with a MIC of less than 0.5 mg.mL-1. The dry ethyl 
acetate extracts exhibited lower antimicrobial activity, which might be explained by solubility problems 
and less diffusion in the agar medium. Results of the bioautographies also confirmed inhibition halos 
corresponding to the active substances present in the leaves, as well as in the flower of C. pyramidalis. 
The phytochemical study of the leaves, bark of the stem, peel of the root, flower and fruit of extracts 
from C. pyramidalis confirmed the presence of a number of known antimicrobial agents including 
ursolic acid, quercetin, catechin, ellagic acid, sitosterol, flavonoids, proanthocyanidins and gallic acid.
Uniterms: Caesalpinia pyramidalis/antimicrobial activity. Caesalpinia pyramidalis/bioautographic 
study. Caesalpinia pyramidalis/antistaphylococcal components. Staphylococcus aureus/multiresistant. 
Brazilian Epidemic Clone.
A determinação da atividade antimicrobiana dos extratos metanólicos e em acetato de etila da folha, 
casca do caule, casca da raiz, flor, fruto e semente de Caesalpinia pyramidalis Tull. foi realizada frente 
a dezessete isolados de Staphylococcus aureus MRSA multirresistentes, dois isolados de S. aureus 
MSSA e duas cepas padrão, pelas técnicas de poço/difusão em ágar e determinação das CMI pelo 
método de diluição em agar/multiinoculador de Stears. O extrato metanólico de casca da raiz indicou 
uma boa atividade, com CMI inferior a 0.5 mg.mL-1. Os extratos secos por extração em acetato de etila 
apresentaram menor atividade que se poderia explicar por problemas de solubilidade e menor difusão no 
meio de cultura em ágar. Resultados das bioautografias confirmaram zonas de inibição correspondente 
às substâncias ativas presente na folha, como também na flor da C. pyramidalis. No estudo fitoquímico 
das folhas, casca da caule, casca da raiz, flor e fruto dos extratos de C. pyramidalis evidenciou-se a 
presença de vários constituintes com reconhecida atividade antimicrobiana, entre estes o ácido ursólico, 
quercetina, catequina, ácido elágico, sitosterol, flavonóides, proantocianidinas e ácido gálico. Entre todos 
os metabólitos citados, somente o ultimo não observamos, por CCD, na casca da raiz de C. pyramidalis.
Unitermos: Caesalpinia pyramidalis/atividade antimicrobiana. Caesalpinia pyramidalis/estudo 
bioautográfico. Caesalpinia pyramidalis/componentes antiestafilocócicos. Staphylococcus aureus/
multirresistente. Clone Epidêmico Brasileiro.
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INTRODUCTION
The importance of nosocomial infection caused by 
Staphylococcus aureus, especially by methicillin resis-
tant S. aureus (MRSA) is well known for its frequency, 
morbidity, mortality and principally for its difficulty to 
treat (Nascimento et al., 2000). The strains of MRSA are 
resistant to all β-lactamics, macrolides, tetracycline, ami-
noglycosides, while the two glycopeptides (vancomycin 
and teicoplanin) remain the only alternatives for clinical 
treatment against infections of MRSA multiresistant S. 
aureus (Shibata et al., 2005). However, S. aureus with 
intermediate susceptibility to vancomycin (VISA) or S. 
aureus glycopeptides (GISA) has recently been identified 
in different countries. Subsequently, strains of S. aureus 
resistant to vancomycin (VRSA) have also emerged, pos-
sessing a different mechanism to those of VISA strains 
(Nishi et al., 2004).
Studies conducted in Brazil have described a clone 
of methicillin resistant Staphylococcus aureus (Brazilian 
Epidemic Clone-BEC, ST247-SCCmecIIIA) that is dis-
seminated and predominates within hospitals throughout 
the country. It was also observed that this clone has spread 
to other countries in South America (Argentine, Chile, 
Colombia, Peru, Ecuador, Uruguay), besides Europe (Por-
tugal, Italy and the Czech Republic) and Asia (Miranda 
et al., 2007; Sola et al., 2002; Rodríguez-Noriega et al., 
2010). In light of this evidence, the need to identify new 
antimicrobial agents is clear.
Caesalpinia pyramidalis Tull., Leguminous family 
(Fabaceae) is a tree found in the Northeastern region of 
Brazil, popularly known as “catingueira”, “pau-de-por-
co” and “mussitaiba”. In folk medicine, its flowers, seeds, 
leaves and bark of the stem are used for the treatment 
of catarrhal infections, diarrheas and dysentery, besides 
being endowed with antipyretic and diuretic properties 
(Mendes et al., 2000; Braga, 1960; Rêgo Júnior et al., 
2011).
A large number of metabolites have been isolated 
from `catingueira`, such as: phenylpropanoids, lupeol, 
β-sitosterol, bioflavonoids (agastiflavone, amentofla-
vone, sequoiaflavone and podocarpusflavone), chalcone, 
kaempferol, apigenin, lignane, stigamasterol and methyl 
gallate (Mendes et al., 2000; Bahia et al., 2010; Novais et 
al., 2003). Crude ethyl acetate from the leaves and roots 
of C. pyramidalis Tull. tested against strains of S. aureus 
and Escherichia coli by the agar disc diffusion method 
showed inhibition halos in the order of 10 mm for the S. 
aureus strains. 
MATERIAL AND METHOD
Collection and identification
The plant was collected in the town of Carnaubeira 
da Penha, in the hinterland of Pernambuco (State), at a 
latitude of 08°19’09”, longitude of 38º44’41” and altitude 
of 446 meters (MME, 2005), between the months of March 
and June, 2004. Samples were identified by employees of 
the Herbarium of the Empresa Pernambucana de Pesquisa 
Agropecuária (IPA), Dr. Rita de Cássia Pereira, and de-
posited with voucher nº 70.008.
Preparation of extracts
For determination of the antibacterial activity of 
C. pyramidalis, different fresh material parts of the plant 
including leaves, bark of the stem, peel of the root, flower, 
seeds and fruit were triturated, weighed and submitted to 
three successive extractions by the process of infusion, 
with medium intervals of 72 hours for each solvent. The 
order of solvents used was n-hexane, followed by ethylic 
acetate and lastly methanol. The extracts thus obtained 
were filtered and solvents evaporated at 40 ºC under 
reduced pressure. These were subsequently weighed and 
their output calculated.
The dry extracts obtained from the methanol extrac-
tion were reintroduced into water/DMSO (1:1 v/v) (Saka-
gami et al., 2005) at a concentration of 100 mg.mL-1. The 
dry extracts obtained from the ethyl acetate and n-hexane 
extractions were also reintroduced in tween 80/water 
(4.8:0.2 v/v) at a concentration of 100 mg mL-1.
Bacteria strains
A total of twenty-one Staphylococcus aureus strains, 
comprising nineteen clinical isolates and two standard 
strains, were used in the study (Table I). These consisted of 
eight multiresistant S. aureus MRSA of the Brazilian epi-
demic clone (BEC), five isolates of the pediatric epidemic 
clone, four isolates of the sporadic clones and two MSSA 
strains which were only resistant to the antibiotics penicil-
lin, erythromycin and gentamycin. The multiresistant S. 
aureus MRSA and S. aureus MSSA were strains from the 
Microbiological Analysis Laboratory collection, derived 
from a study on the susceptibility/resistance profile of S. 
aureus in Recife-Pernambuco state (Cordeiro, 2004).
Preparation of inoculates
The inoculates were prepared starting with the 24 h 
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TABLE I - List of Staphylococcus aureus strains assayed
Reg. Nº Profile Clone Origin
AM723 MRSA A1 Catheter point
AM793 MRSA A1 Tracheal secretion
AM799 MRSA A5 Vesical probe point
AM837 MRSA A7 Catheter point
AM858 MRSA A13 Catheter point
AM895 MRSA A6 Hemoculture
AM902 MRSA A2 Orifice secretion
AM948 MRSA A9 Catheter point
AM599 MRSA B3 Ulcer Secretion
AM642 MRSA B5 Secretion
AM771 MRSA B2 Tracheal secretion
AM922 MRSA B6 Left leg wound
AM942 MRSA B4 Hemoculture
AM594 MRSA F Catheter point
AM872 MRSA G Urine
AM875 MRSA D Hemoculture
AM876 MRSA I Hemoculture
AM632 MSSA - Operation wound
AM672 MSSA - Tracheal secretion
AM103 - - ATCC 6538
AM106 - - ATCC 6538P
Reg. Nº: Register Number; AM: Microbiological analysis 
laboratory collection – Pharmaceutical Science Department 
–UFPE; ATCC: American type culture collection; Clone A: 
Brazilian epidemic clone (BEC); Clone I, D, G, F: Sporadic 
clone; Clone B: Pediatric clone; MRSA: Methicillin resistant 
Staphylococcus aureus; MSSA: Methicillin sensitive 
Staphylococcus aureus
colonies culture of S. aureus in Mueller-Hinton agar and 
suspended in sterile physiological solute, comparing 
the turbidity with the 0.5 tube of the McFarland scale 
(108 UFC mL-1) (CLSI, 2003).
Agar well diffusion method
The inoculum were applied to the surface of the 
Mueller-Hinton agar and after perforation of the wells 
(perforator 6 mm in diameter), 100 µL of the extracts 
(concentrations of 100 mg .mL-1 and 50 mg mL-1), stan-
dard antibiotic (300 µg mL-1) and of the control solution 
(DMSO at 50% (v/v) or tween 80 at 4% (v/v)) were added 
to each well. After incubation at 37 ºC ± 1 for 24 hours, the 
diameter of the inhibition halos were measured and results 
evaluated according to the following scale: inhibition 
halos of 9 mm - inactive; 9-12 mm - somewhat active; 13-
18 mm - active; 18mm - very active (Alves et al., 2000).
Agar dilution method – Determination of 
Minimum Inhibitory Concentration (MIC)
The minimum inhibitory concentration for the ex-
tracts (basic solution of 20 mg.mL-1), dilutions in water 
with concentrations of 312.5 µg.mL-1 to 20.103 µg.mL-1, 
had been prepared and incorporated to Mueller-Hinton 
agar (1:9), thus final concentrations of 31.5 µg.mL-1 to 
2000 µg.mL-1 of the extracts remained. The standard anti-
biotics used were tetracycline and oxacillin (Sigma), with 
concentrations as indicated by the CLSI (2003) norms.
The twenty-one inoculates were distributed asepti-
cally in the Stears multi-inoculator, and then deposited on 
the surface of the culture medium, and incubated at 36 ºC 
± for 24 hours. 
Duplicate controls were performed at the beginning 
and end of the inoculation control process. Control of the 
diluents was also done (tween 80 at 4% and DMSO at 
50%).
The results were interpreted comparatively to the 
strain controls and determined by the first plate whose 
concentration inhibited growth.
Phytochemical analysis
Thin layer chromatography (TLC) with silica-gel 
GF°254 (Merck) was used. The methanol or ethyl acetate 
extracts of the leaves and flower of Caesalpinia pyramida-
lis at the concentration of 20 mg mL-1 were applied using 
an analytic capillary (15 µL). The mobile phase for the 
methanol extracts was the chromatographic system (1): 
AcOEt/MeOH/H2O (81:11:08), while for the correspond-
ing ethyl acetate the system (2): AcOEt/HCOOH/AcOH/
H2O (100:2:2:2 and 100:3:3:3) was employed. TLC was 
performed in duplicate, one being used as a chromato-
graphic reference and the other for bioautography.
In the phytochemical study, standards of gallic acid, 
ellagic acid, quercetin, kaempferol, catechin, ursolic acid, 
β-sitosterol, β-amyrin, pilocarpine, iridoids, and glucose 
were used.
The visualization of TLC was carried out under UV 
light (254 and 366 nm), as shown in Table II.
Bioautographic technique
The developed TLC according to system (1) was 
subjected to aseptic current air for 5 minutes, and another 
developed by system (2) for 6h, respectively. On the TLC 
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surface, melted Mueller-Hinton agar (MH) was added, 
inoculated with a saline suspension of S. aureus ATCC 
6538 (bacterial suspension at 108 UFC/mL) and homoge-
neously distributed over the TLC plate. After solidification 
of inoculated MH, it was left for 30 minutes at the sur-
rounding ambient temperature of 25 ºC for predifusion of 
the active components. Subsequently, it was incubated for 
24 to 36 hours ±1 ºC. After this period the bioautography 
was revealed with a solution of 2,3,5-triphenyltetrazolium 
chloride (TTC) at 2.5 mg mL-1 and incubated for a further 
4 hours.
The presence of an inhibition zone indicated the 
existence of active components (Pessini et al., 2003).
RESULTS AND DISCUSSION
Antimicrobial activity
The results of methanol and ethyl acetate extracts 
from C. pyramidalis against four clinical isolates and 
one standard strain (AM103) of S. aureus are given in 
Table III. The hexane extracts showed no activity. The 
diameters of the inhibition halos expressed in millimeters 
are expressed in the form of a table for each extract and 
each bacterium.
The MIC values of the assayed extracts are shown 
separately, according to type of S. aureus MRSA multi-
resistant clone. Table IV summarizes the results of eight 
Brazilian epidemic clones, five pediatric clones, four 
sporadic multiresistant clones, two strains of S. aureus 
MSSA, and finally two standard strains.
TABLE II - Chromatographic systems used for phytochemical screening of Caesalpinia pyramidalis Tull.
Metabolites Elution System Revelator Reference
Alkaloids A Dragendorff Wagner et al., 1984
Triterpenoids and Esteroids B Liebermann-Burchard Harbone, 1998
Iridoids A Sulfuric Vanilin Wagner et al., 1984
Saponins A Anisaldehyde Wagner and Bladt, 1996
Sugars C TTC Metz, 1961
Coumarins D U.V Wagner, Bladt, 1996
Cinnamic Derivatives A NEU Wagner, Bladt, 1996
Flavonoid A NEU Wagner et al., 1984
Markham, 1982
Phenylpropane glycosides A NEU Wagner, Bladt, 1996
Condensed Proanthocyanidine 
and Leucoanthocyanidines
A Chloridric Vanillin Robertson et al., 1957
A: EtOAc-HCOOH-AcOH-H2O (100:11:11:26 v/v); B: EtOAc-HCOOH-AcOH-H2O (100:0.5:0.5:0.5 v/v); C: n-BuOH-Me2CO- 
Buffer Phosphate pH = 5.0 (40:50:10 v/v); D: Et2O-toluene-AcOH 10% (50:50:50 v/v); NEU: 2-Amino-ethyl-diphenyl borinate, 
TTC: Triphenyl Tetrazolium Chloride.
TABLE III - Antimicrobial activity of Caesalpinia pyramidalis 
against S. aureus
Extracts mg/Well
S. aureus (AM) halo diameter in mm
594 723 922 942 103
LM 10 mg 18 20 20 21 20
5 mg 15 15 16 18 16
BM 10 mg 20 18 18 19 21
5 mg 17 15 16 16 19
RM 10 mg 19 16 17 17 20
5 mg 19 16 17 17 20
FLM 10 mg 20 22 22 22 23
5 mg 17 18 18 19 21
FM 10 mg 20 20 19 21 23
5 mg 18 18 16 19 20
SM 10 mg 17 16 19 17 20
5 mg 15 14 16 16 18
LA 10 mg - - - - 12
5 mg - - - - -
BA 10 mg 16 15 15 16 18
5 mg 14 13 12 12 14
RA 10 mg 18 18 20 19 20
5 mg 16 17 16 17 18
FA 10 mg 14 13 12 18 18
5 mg 12 - - 15 -
TT 30 mcg 11 12 27 12 28
L: (leaves); FL (flower); B (bark of stem); R (peel of root); 
F (fruit); S (seeds); M (methanol); A (ethyl acetate) TT: 
Tetracycline; AM: Microbiological analysis laboratory 
collection – Pharmaceutical Science Department –UFPE
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TABLE IV - Minimum Inhibitory Concentration (MIC) of extracts from Caesalpinia pyramidalis against Staphylococcus aureus 
strains
STRAINS
MIC of extracts from Caesalpinia pyramidalis (mg mL-1) MIC of Antibiotics 
(mg mL-1)
Antibiotics
LM BM RM FLM FM SM RA FA BA Tet Oxa Sensitive Resistant
AM 723 1 1 1 2 >2 >2 2 >2 2 0.032 0.064 1 2, 3, 4, 5, 6, 7, 8
AM 793 1 1 0.5 0.5 1 1 0.25 1 >2 >0.064 0.256 1 2, 3, 4, 5, 6, 7, 8
AM 799 1 1 0.5 0.5 2 1 0.25 0.5 >2 0.064 0.256 1 2, 3, 4, 5, 6, 7, 8
AM 837 2 2 1 1 NT NT NT NT 2 0.032 0.256 1 2, 3, 4, 5, 6, 7, 8
AM 858 1 1 0.25 1 NT NT NT NT >2 0.032 0.256 1 2, 3, 4, 5, 6, 7, 8
AM 895 1 1 0.5 1 2 1 0.25 1 NT 0.064 0.064 1 2, 3, 4, 5, 6, 7, 8
AM 902 >2 >2 1 2 NT NT NT NT 2 >0.064 0.032 1 2, 3, 4, 5, 6, 7, 8
AM 948 NT NT 0.5 0.5 2 >2 1 0.5 2 0.064 0.256 1 2, 3, 4, 5, 6, 7, 8
AM 599 2 >2 1 1 2 2 NT 1 >2 0.001 0.016 1, 2, 4, 7, 5 3, 6, 8
AM 642 2 2 1 1 2 1 >2 2 >2 0.0005 0.032 1, 7, 5, 4 3, 2, 6, 8
AM 771 2 1 0.5 0.5 >2 1 NT 0.5 2 0.0005 0.032 1, 2, 4, 7, 5 3, 6, 8
AM 922 >2 1 1 1 1 2 2 1 2 0.002 0.064 1, 2, 3, 4, 7 6, 8, 5
AM 942 1 0.5 1 1 1 >2 NT 2 2 0.032 0.016 1, 2, 3, 5, 7 4, 6, 8
AM 594 0.5 1 1 1 2 2 >2 0.125 1 0.032 0.256 1 3, 4, 6, 2, 7, 5, 8
AM 872 >2 1 1 2 >2 >2 NT 0.125 >2 0.016 0.128 1, 2, 3, 5, 7 4, 6, 8
AM 875 2 2 0.5 1 2 2 NT 0.5 2 0.0005 0.016 1, 2, 4, 7, 5 3, 6, 8
AM 876 2 2 0.5 0.5 2 1 >2 0.5 2 0.002 0.032 1, 2, 3, 4, 7, 5 6, 8
AM 632 2 2 1 1 2 1 2 1 >2 0.001 0.00013 1, 2, 6, 4, 7, 5 3, 8
AM 672 2 2 NT NT >2 1 2 0.5 >2 0.001 0.00013 1, 2, 3, 4, 6, 7 5, 8
AM 103 2 2 0.5 0.5 2 1 2 0.25 2 0.00025 0.00006  ATCC 6538
AM 106 2 1 0.5 1 2 0.5 >2 0.25 2 0.00025 0.00013 ATCC 6538P
NT: Not tested; L: (leaves); FL (flower); B (bark of stem); R (peel of root); F (fruit); S (seeds); M (methanol); A (ethyl acetate).; (1) – vancomycin; 
(2) – ciprofloxacin; (3) – erythromycin; (4) –tetracycline (Tet); (5) – gentamicin; (6) – oxacillin (Oxa); (7) – sulfamethoxazole/trimethoprim; 
(8) – penicillin.; AM: Microbiological analysis laboratory collection – Pharmaceutical Science Department –UFPE
Bioautography
The bioautographic results for the leaves and flower 
extracted in methanol and ethyl acetate, and peel of the 
root extracted in ethyl acetate, from C. pyramidalis are 
listed in Table V.
TABLE V - Retention factor values related to inhibition halos of extracts of Caesalpinia pyramidalis obtained by bioautographic 
technique
Chromatograph Systems Extracts Retention Factor (Rfs)
AcOEt/MeOH/H2O (81:11:08) LM 0.55 0.84 0.94
FLM 0.19 0.29 0.48
AcOEt/HCOOH/AcOH/H2O (100:2:2:2 and 100:3:3:3) LA 0.51 0.62 0.80 0.94
FLA 0.62
RA 0.26 0.39 0.58 0.68
L: (leaves); FL (Flower); R (Peel of Root); M (Methanol); A (Ethyl Acetate); AcOEt: Ethyl acetate, MeOH: Methanol, HCOOH: 
Formic Acid, AcOH: Acetic Acid.
Phytochemical study
The secondary metabolites found in the extracts of 
the parts studied from C. pyramidalis with well-known 
antimicrobial activity are shown in Table VI.
Among the two techniques used for the determina-
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TABLE VI - Secondary metabolites from Caesalpinia pyramidalis with well-known antimicrobial activity
Secondary Metabolites
Caesalpinia pyramidalis
Leaves Stem of Bark Peel of Root Fruit Flower
Ursolic Acid (-) (-) + (-) (-)
Sitosterol + + + + +
Cinnamic Derivatives + + + + +
Flavanoids of Aglicones + + + + +
Quercetin (-) (-) + (-) (-)
Condensed Proanthocyanidins (-) + + (-) (-)
Catechin (-) + + (-) (-)
Gallic Acid (-) (-) (-) + +
Ellagic Acid (-) (-) + + +
+: Metabolite Present; (-): Metabolite Absent
tion of antimicrobial activity, the agar well diffusion tech-
nique, despite using larger volumes (100 µL) (Caetano et 
al., 2002) compared to disks (10 µL) (Voravuthikunchai 
and Kitppipit, 2005), has the advantage of allowing the 
use of adjuvant to improve the solubility of the extract 
constituents and to permit radial as well as superficial 
diffusions, conditions resulting in better inhibition halos.
With regard to the five Staphylococcus aureus strains 
studied, four represent the three types of MRSA multire-
sistant clones and one the standard strain.
In Table III, the extract of the flower methanol 
(FLM) showed the largest inhibition halos for the five 
tested strains, with values in the order of 22 mm, at the 
highest concentration (10 mg/well), corresponding to the 
very active classification (Alves et al., 2000), and halos in 
the order of 16 mm for concentrations of 5 mg per well , 
with extracts of leaves, peel of the root, fruit and seed also 
having good activity.
In general, extracts from retrieval in ethyl acetate 
showed smaller inhibition halos compared with those ex-
tracted from methanol. This fact can be due to the polarity 
characteristics of its constituents which resulted in lower 
diffusion in aqueous environs and therefore produced 
smaller inhibition halos despite having substances with 
antimicrobial activity (Lenette et al., 1987).
Observing Table III of the corresponding extracts 
(leaves, bark of the stem, peel of the root, fruit and seed) 
in ethyl acetate, the extract of peel of the root produced 
inhibition halos in the order of 20 mm, while the extract of 
the leaves showed no activity except against the standard 
strain (AM103). Experimentally, this difference may be 
explained by the fact that the dry extract of peel of the 
root is in the form of powder and dissolved very well in 
tween 80/water 4% whereas extract from the leaves had a 
pasty consistency and was not well dissolved, hindering 
its solubility. 
The inhibition zone produced by the standard anti-
biotic, tetracycline, confirmed the resistance phenotype 
of the clone strains, i.e. Staphylococcus aureus MRSA 
AM594, S. aureus AM723 and S. aureus AM942, resistant 
to tetracycline had inhibition halos in the order of 13 mm 
or less while the strains S. aureus MRSA AM922 and S. 
aureus AM103 sensitive to tetracycline had inhibition 
halos in the order of 26 mm. 
Finally, the two diluents, DMSO at 50% and tween 
80 at 4%, exhibited no inhibition.
The presented data are mean values of two deter-
minations.
On the other hand, the presence of active substances 
in the leaves as well as in the flower for both types of ex-
tracts was evidenced in the results of the bioautographies 
(Table V).
The bioautography technique permits the detection 
of inhibition halos that reveal the presence of active sub-
stances in the TLC (Pessini et al., 2003) against S. aureus 
ATCC 6538 in the methanolic extracts, one in Rƒ 0.48 
for the flower extract and Rƒ 0.55 for the leaves extract. 
Similarly, for the extracts in ethyl acetate, one showed 
the presence of inhibition halos in Rƒ 0.62 for the flower 
extract, the Rƒ 0.51, Rƒ 0.62, Rƒ 0.80 and Rƒ 0.94 for the 
leaves extract and the Rƒ 0.26, Rƒ 0.39, Rƒ 0.58, Rƒ 0.68, 
, Rƒ 0.77 and Rƒ 0.92 for the stem bark extract (Table V). 
The phytochemical investigation evidenced the 
presence of substances such as flavonoids (flavonoid 
aglycones), sitosterol and cinnamic derivatives for all the 
extracts of C. pyramidalis tested. The presence of gallic 
acid and ellagic acid was also evidenced in the flower 
extract in methanol . Other components identified were 
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polyphenols (phenolic acid) in the fruit, and ursolic acid 
and quercetin from the bark of the stem and peel of the root 
(root and bark of the stem) thus confirming data from the 
literature (Bahia et al., 2010; Bahia et al., 2005).
With reference to MIC (Table IV), analysis of the re-
sults reveals that, in the case of S. aureus MRSA Brazilian 
epidemic clone, that some of the values are less than 0.5 
mg.mL-1 for the methanol extracts as well as ethyl acetate 
extracts of the peel of the root.
Similar results were found for the methanol extract 
of the flower.
The MIC values for the five pediatric clones were 
again low for the extracts of the peel of the root, being in 
the order of 0.25 mg.mL-1 for both methanol and ethyl 
acetate extracts.
Also, in Table IV featuring MIC for the four spo-
radic clones together with the susceptible S. aureus 
MSSA strains and standard strains, the extracts of the 
peel of the root in ethyl acetate had some values as low as 
0.125 mg mL-1, even less than those of the MSSA strains 
(0.5 mg mL-1) and standard strains (0.25 mg mL-1). 
The MIC values of tetracycline and oxacillin con-
firmed the phenotype resistance and MRSA or MSSA 
character of isolates of S. aureus strains, respectively.
In relation to the DMSO diluents at 50% and tween 
80 at 4%, these showed no inhibition against any of the 
twenty-one strains, confirming earlier data for DMSO by 
Sakagami et al. (2005).
CONCLUSION
The extracts from C. pyramidalis showed good 
antimicrobial activity against the S. aureus multiresistant 
strains. Also, the bioautography technique allowed visual-
izing six inhibition halos for the extracts in ethyl acetate 
from stem bark and three from the leaves, which allows 
us to conclude that there are at least six plus three active 
compounds, respectively.
Further experiments aimed at the isolation and struc-
tural identification of the active compounds are needed, as 
well as more pharmacological data to validate the popular 
use of the extracts from the C. pyramidalis. such as data 
determining its safety and toxicity.
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